HM61713, an EGFR-mutant selective inhibitor

Date 04 March 2015
Event 13th International Congress on Targeted Anticancer Therapies
Session Mutant-specific kinase inhibitors
Topics Cytotoxic agents
Clinical research
Basic Scientific Principles
Therapy
Biological therapy
Presenter Dong-Wan Kim